18F-氟吡啶嗪PET心肌灌注显像的总灌注缺损定量诊断效能
本研究基于III期试验中729例患者的18F-氟吡啶嗪PET心肌灌注显像数据,以定量冠状动脉造影为参照,用ROC分析评估自动总灌注缺损(TPD)在≥70%和≥50%狭窄端点上的诊断效能。TPD在整体和血管水平与视觉评分及缺损范围定量的诊断效能相似,仅在右冠状动脉略优、左回旋支略低。
要点
- TPD在≥70%狭窄时整体诊断准确率74%,与视觉评分(75%、71%)和缺损范围(72%)相似(P≥.05)。
- 血管水平TPD对右冠状动脉准确率77%略高于缺损范围的72%(P=.03),对左回旋支74%略低于视觉评分的79%(P=.03)。
- ≥50%狭窄端点观察到相似结果。
核心结论
- 自动TPD对整体和区域18F-氟吡啶嗪PET心肌灌注显像的诊断效能分别与视觉评分和缺损范围定量相似。
研究设计与样本
- 基于III期试验的18F-氟吡啶嗪相对灌注图像与定量冠状动脉造影数据,采用受试者工作特征分析,在≥70%和≥50%狭窄两个端点评估TPD在患者水平(整体左心室)和血管水平的诊断效能。
- 使用来自氟吡啶嗪试验人群25例患者数据创建的正常灌注数据库,在其余729例试验患者中计算TPD。
主要发现
- 在≥70%狭窄阈值,TPD整体诊断准确率74%,与既往发表的视觉评分(75%、71%)及缺损范围(72%)相似(P≥.05)。
- 血管水平,TPD对左前降支和左回旋支的准确率分别为79%和74%,与缺损范围的80%和72%相似;对右冠状动脉准确率77%高于缺损范围的72%(P=.03)。
- 血管水平,TPD对左前降支和右冠状动脉的准确率分别为77%和79%,与视觉评分的76%和76%相似;对左回旋支准确率74%低于视觉评分的79%(P=.03)。
- 在≥50%狭窄端点观察到相似结果。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To assess the diagnostic performance of 18F-flupiridaz positron emission tomography (PET) myocardial perfusion imaging (MPI) for coronary artery disease detection using total perfusion deficit (TPD), an automated metric of combined disease extent and severity. METHODS: Flurpiridaz relative perfusion images and quantitative coronary angiography data from the initial phase III trial were evaluated using receiver operating characteristic analysis at separate endpoints of ≥70% stenosis and ≥50% stenosis, to determine the diagnostic performance of TPD at per-patient (global LV) and per-vessel levels. TPD results at both endpoints were compared with the performance of visual scores and defect extent values available from two previous publications. RESULTS: Using a normal perfusion database that was created with the data of 25 patients from the flurpiridaz trial population, TPD was calculated in the remaining 729 trial patients. At the threshold of ≥70% stenosis, TPD was observed to have similar (P ≥ .05) per-patient diagnostic performance (74% accuracy) to visual scoring from previous publications (75%, 71%), as well as defect extent (72%). At the per-vessel level, the TPD achieved similar performance to defect extent in the left anterior descending artery (LAD) and left circumflex artery (LCx) (79%, 74% vs 80%, 72% accuracy) with slightly higher accuracy in the right coronary artery (RCA) (77% vs 72%, P = .03), and similar performance to visual scoring in the LAD and RCA (77, 79% vs 76%, 76% accuracy) with marginally lower performance in the LCx (74% vs 79%, P = .03). Similar results were observed at the ≥50% obstructive disease endpoint. CONCLUSIONS: Automated TPD demonstrated similar diagnostic performance for global and regional flurpiridaz PET MPI, respectively, to visual scoring and defect extent quantification.
引用
- Renaud JM, Moody JB, Vanderver MD, et al. Diagnostic performance of 18F-flurpiridaz PET myocardial perfusion imaging with total perfusion deficit quantification. J Nucl Cardiol. 2025. PMID: 40527442. doi:10.1016/j.nuclcard.2025.102266
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。